DEXCOM INC/ US2521311074 /
2024-06-07 5:32:19 PM | Chg. +0.88 | Volume | Bid5:32:19 PM | Ask5:32:19 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
106.60EUR | +0.83% | 0 Turnover: - |
-Bid Size: - | -Ask Size: - | 42.63 bill.EUR | - | - |
GlobeNewswire
04-08
Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer
GlobeNewswire
01-31
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.